ECM
NVS icon

Endurant Capital Management’s Novartis NVS Stock Holding History

Endurant Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-47,095
Closed -$4.15M – 88
2015
Q2 		$4.15M Sell
47,095
-21,651
-31% -$1.99M 1.22% 29
2015
Q1 		$6.07M Sell
68,746
-10,713
-13% -$950K 2.01% 14
2014
Q4 		$6.6M Buy
+79,459
New +$6.59M 2.59% 12

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Endurant Capital Management's NVS Position: Q3 2015 in Review

Endurant Capital Management sold out of Novartis (NVS) in Q3 2015, closing a stake of 47,095 shares — an estimated $4.15M sold.

Endurant Capital Management first reported a position in NVS in Q4 2014 and held it in 3 quarters. The position peaked at $6.6M in Q4 2014. 925 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

  • Endurant Capital Management reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
  • Endurant Capital Management sold 47,095 Novartis shares in Q3 2015, an estimated $4.15M.
  • Endurant Capital Management first reported a position in Novartis in Q4 2014 and held it in 3 quarters.
  • Endurant Capital Management's Novartis position peaked at $6.6M in Q4 2014.
  • 925 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Endurant Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.